Video: Boosting the efficacy and reducing the toxicity of the chemotherapy drug methotrexate

Naama Kanarek, a postdoctoral researcher in the lab of Whitehead Member David Sabatini, explains how new genetic tools are allowing insights into the sensitivity of cancer cells to methotrexate and discusses how research might help address some of the challenges of methotrexate chemotherapy treatment.

  

Topics

Contact

Communications and Public Affairs
Phone: 617-452-4630
Email: newsroom@wi.mit.edu